Protease Biotherapeutics
Filed in archive Corporate and Industrial News , Genomics, Proteomics and Bioinformatics , Patents and Intellectual Property Rights on August 8, 2005
Not all discoveries from basic research can be used to fuel a start-up biotech venture. Often, it makes better (financial) sense to simply license the intellectual property. Last week, for example, Torrey Pines Institute for Molecular Studies entered into an exclusive worldwide license agreement with Catalyst Biosciences, Inc. that would grant Catalyst the use of the Institute's seminal intellectual property covering protease engineering, selection and optimization. Proteases are naturally-occurring, protein-degrading enzymes that are useful as biotherapeutics against inflammation, cardiovascular diseases and other disorders.
According to TPIMS President and director Richard Houghten,
"This agreement represents an example of how the Institute's fundamental technologies are being broadly applied to ground breaking science and drug discovery. The protease selection technology should allow Catalyst to rapidly identify and advance protease biologic leads in a manner analogous to high-throughput small molecule lead discovery and optimization."
The bottomline: To take the fastest route to bringing the results of federally-funded research into some useful form that benefits the public.
Read the press release here.
Permalink: Protease Biotherapeutics
Tags: protease lead+discovery biotech biotherapeutics corporate protease+biotherapeutics intellectual+prop
Vote for Protease Biotherapeutics:
|
Rating: 7.33 out of 3 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
